Showing results (1361-1370 of 1,568) with videos related to
Sort By:
Pageof 157
Expert Review of Hematology|May 27, 2021
Effectiveness of ankle fusion in patients with hemophilia, advanced ankle degeneration, and unbearable pain for whom nonsurgical and surgical treatments have been ineffectiveE Carlos Rodriguez-Merchan, Carlos A Encinas-Ullan, Primitivo Gomez-CarderoExpert Review of Hematology|May 28, 2021
Immunodeficiency-associated Hodgkin lymphomaAntonino Carbone, Annunziata Gloghini, Diego Serraino, et al.Expert Review of Hematology|February 21, 2020
Stem cell transplant for the treatment of myelofibrosisLara Mannelli, Paola Guglielmelli, Alessandro M VannucchiExpert Review of Hematology|February 8, 2020
Refeeding syndrome in hematological cancer patients - current approachNicola Szeja, Sebastian GrosickiExpert Review of Hematology|February 11, 2020
Toxicities of novel therapies for hematologic malignanciesFlorian Simon, Jorge Garcia Borrega, Paul J BröckelmannExpert Review of Hematology|March 10, 2020
Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRdAjai Chari, Paul G Richardson, Dorothy Romanus, et al.Expert Review of Hematology|July 13, 2021
Exploiting gene mutations and biomarkers to guide treatment recommendations in mantle cell lymphomaAndre GoyExpert Review of Hematology|July 15, 2021
The expression of CD30 and its clinico-pathologic significance in peripheral T-cell lymphomasKennosuke Karube, Yoshihide Kakimoto, Yukio Tonozuka, et al.Expert Review of Hematology|June 14, 2021
Health-related quality of life in patients with acute promyelocytic leukemia: a systematic literature reviewFabio Efficace, Laura Cannella, Massimo Breccia, et al.Expert Review of Hematology|July 5, 2022
Fedratinib, the first selective JAK2 inhibitor approved for treatment of myelofibrosis - an option beyond ruxolitinibChandan Saha, Claire HarrisonPageof 157